Education
About Us
Working with TipRanks
Follow Us
Hydration Pharmaceuticals Co. Ltd. (AU:HPC)
ASX:HPC
RESEARCH TOOLSreports
Total Valuation
Hydration Pharmaceuticals Co. Ltd. has a market cap or net worth of ―. The enterprise value is ―.
Market Cap―
Enterprise Value―
Share Statistics
Hydration Pharmaceuticals Co. Ltd. has 383,300,930 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding383,300,930
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Hydration Pharmaceuticals Co. Ltd.’s return on equity (ROE) is 0.97 and return on invested capital (ROIC) is -151.88%.
Return on Equity (ROE)0.97
Return on Assets (ROA)0.53
Return on Invested Capital (ROIC)-151.88%
Return on Capital Employed (ROCE)-1.52
Revenue Per Employee―
Profits Per Employee―
Employee Count―
Asset Turnover0.64
Inventory Turnover1.45
Valuation Ratios
The current PE Ratio of Hydration Pharmaceuticals Co. Ltd. is 0.52. Hydration Pharmaceuticals Co. Ltd.’s PEG ratio is >-0.01.
PE Ratio0.52
PS Ratio0.00
PB Ratio0.65
Price to Fair Value0.51
Price to FCF-1.17
Price to Operating Cash Flow-0.85
PEG Ratio>-0.01
Income Statement
In the last 12 months, Hydration Pharmaceuticals Co. Ltd. had revenue of 3.20M and earned 2.67M in profits. Earnings per share was 0.02.
Revenue3.20M
Gross Profit1.62M
Operating Income-4.20M
Pretax Income-5.67M
Net Income2.67M
EBITDA-3.91M
Earnings Per Share (EPS)0.02
Cash Flow
In the last 12 months, operating cash flow was -4.91M and capital expenditures 0.00, giving a free cash flow of -4.91M billion.
Operating Cash Flow-4.91M
Free Cash Flow-4.91M
Free Cash Flow per Share-0.01
Dividends & Yields
Hydration Pharmaceuticals Co. Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-1.07
52-Week Price Change0.00%
50-Day Moving Average0.01
200-Day Moving Average―
Relative Strength Index (RSI)33.38
Average Volume (3m)399.52K
Important Dates
Hydration Pharmaceuticals Co. Ltd. upcoming earnings date is Aug 28, 2025, Before Open (Confirmed).
Last Earnings DateFeb 28, 2025
Next Earnings DateAug 28, 2025
Ex-Dividend Date―
Financial Position
Hydration Pharmaceuticals Co. Ltd. as a current ratio of 2.24, with Debt / Equity ratio of 0.00%
Current Ratio2.24
Quick Ratio1.75
Debt to Market Cap0.00
Net Debt to EBITDA0.82
Interest Coverage Ratio-2.38
Taxes
In the past 12 months, Hydration Pharmaceuticals Co. Ltd. has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate<0.01
Enterprise Valuation
Hydration Pharmaceuticals Co. Ltd. EV to EBITDA ratio is 0.47, with an EV/FCF ratio of 0.60.
EV to Sales-0.57
EV to EBITDA0.47
EV to Free Cash Flow0.60
EV to Operating Cash Flow0.60
Balance Sheet
Hydration Pharmaceuticals Co. Ltd. has AU$853.96K in cash and marketable securities with $4.70M in debt, giving a net cash position of AU$3.85M billion.
Cash & Marketable SecuritiesAU$853.96K
Total Debt$4.70M
Net CashAU$3.85M
Net Cash Per ShareAU$0.01
Tangible Book Value Per ShareAU$0.02
Margins
Gross margin is 56.00%, with operating margin of -130.95%, and net profit margin of 83.23%.
Gross Margin56.00%
Operating Margin-130.95%
Pretax Margin-177.05%
Net Profit Margin83.23%
EBITDA Margin-122.02%
EBIT Margin-122.02%
Analyst Forecast
The average price target for Hydration Pharmaceuticals Co. Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-3.04%
EPS Growth Forecast45.30%